Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Grifols, S.A Total Change in Assets/Liabilities 2012-2025 | GRFS

Grifols, S.A annual/quarterly total change in assets/liabilities history and growth rate from 2012 to 2025. Total change in assets/liabilities can be defined as the sum of all line items in the Asset/Liability section of the Cash Flows Statement
  • Grifols, S.A total change in assets/liabilities for the quarter ending June 30, 2025 was $-0.295B, a 65.79% increase year-over-year.
  • Grifols, S.A total change in assets/liabilities for the twelve months ending June 30, 2025 was $-1.057B, a 1.27% decline year-over-year.
  • Grifols, S.A annual total change in assets/liabilities for 2024 was $0.024B, a 106.05% decline from 2023.
  • Grifols, S.A annual total change in assets/liabilities for 2023 was $-0.4B, a 37.68% decline from 2022.
  • Grifols, S.A annual total change in assets/liabilities for 2022 was $-0.642B, a 285.03% increase from 2021.
  
Grifols, S.A Annual Total Change in Assets/Liabilities
(Millions of US $)
2024 $24
2023 $-400
2022 $-642
2021 $-167
2020 $121
2019 $-539
2018 $-133
2017 $-74
2016 $-182
2015 $-86
2014 $0
2013 $54
2012 $-56
2011 $-71
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.786B $7.805B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $72.304B 27.81
Zoetis (ZTS) United States $68.600B 24.89
Takeda Pharmaceutical (TAK) Japan $47.633B 9.72
Daiichi Sankyo, - (DSNKY) Japan $46.412B 23.79
BeOne Medicines - (ONC) Switzerland $32.657B 0.00
Sandoz Group AG (SDZNY) Switzerland $27.720B 0.00
Summit Therapeutics (SMMT) United States $18.140B 0.00
Merck (MKKGY) Germany $16.327B 10.62
Shionogi (SGIOY) Japan $14.836B 14.86
United Therapeutics (UTHR) United States $13.859B 11.99
Neurocrine Biosciences (NBIX) United States $13.780B 41.11
IPSEN (IPSEY) France $11.603B 0.00
Orion OYJ (ORINY) Finland $11.203B 27.00
Madrigal Pharmaceuticals (MDGL) United States $9.707B 0.00
Eisai (ESAIY) $9.076B 10.24
Corcept Therapeutics (CORT) United States $7.332B 61.58
Stevanato Group S.p.A (STVN) Italy $7.105B 41.89
Ionis Pharmaceuticals (IONS) United States $6.793B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.740B 19.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.436B 0.00
Soleno Therapeutics (SLNO) United States $3.636B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.999B 14.25
Crinetics Pharmaceuticals (CRNX) United States $2.886B 0.00
Hypermarcas (HYPMY) Brazil $2.831B 21.29
Procaps Group, S.A (PROCF) Luxembourg $2.799B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.697B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.494B 8.35
Centessa Pharmaceuticals (CNTA) United Kingdom $2.218B 0.00
Ocular Therapeutix (OCUL) United States $2.178B 0.00
Dyne Therapeutics (DYN) United States $1.956B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.778B 0.00
Guardian Pharmacy Services (GRDN) United States $1.656B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.590B 23.69
Ardelyx (ARDX) United States $1.537B 0.00
Harrow (HROW) United States $1.443B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.420B 0.00
Xeris Biopharma Holdings (XERS) United States $1.276B 0.00
ARS Pharmaceuticals (SPRY) United States $1.271B 0.00
Evotec AG (EVO) Germany $1.246B 0.00
Collegium Pharmaceutical (COLL) United States $1.208B 6.60
Enliven Therapeutics (ELVN) United States $1.206B 0.00
Cronos Group (CRON) Canada $0.996B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.840B 0.00
Akebia Therapeutics (AKBA) United States $0.830B 0.00
ProKidney (PROK) United States $0.736B 0.00
Elite Pharmaceuticals (ELTP) United States $0.705B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.705B 7.27
Theravance Biopharma (TBPH) United States $0.704B 58.21
KalVista Pharmaceuticals (KALV) United States $0.680B 0.00
Organogenesis (ORGO) United States $0.650B 0.00
Relay Therapeutics (RLAY) United States $0.636B 0.00
Bioventus (BVS) United States $0.599B 14.50
Tourmaline Bio (TRML) United States $0.592B 0.00
Siga Technologies (SIGA) United States $0.588B 7.27
Xencor (XNCR) United States $0.574B 0.00
USANA Health Sciences (USNA) United States $0.573B 11.75
Oruka Therapeutics (ORKA) United States $0.572B 0.00
Savara (SVRA) United States $0.565B 0.00
Nektar Therapeutics (NKTR) United States $0.558B 0.00
Zevra Therapeutics (ZVRA) United States $0.522B 0.00
Esperion Therapeutics (ESPR) United States $0.446B 0.00
Nanobiotix S.A (NBTX) France $0.443B 0.00
Aquestive Therapeutics (AQST) United States $0.382B 0.00
Aldeyra Therapeutics (ALDX) United States $0.351B 0.00
Altimmune (ALT) United States $0.327B 0.00
Larimar Therapeutics (LRMR) United States $0.324B 0.00
Nature's Sunshine Products (NATR) United States $0.291B 18.99
4D Molecular Therapeutics (FDMT) United States $0.289B 0.00
AleAnna (ANNA) United States $0.281B 0.00
Galectin Therapeutics (GALT) United States $0.272B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.270B 0.00
Lexeo Therapeutics (LXEO) United States $0.257B 0.00
Korro Bio (KRRO) United States $0.222B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.214B 33.00
Lyell Immunopharma (LYEL) United States $0.213B 0.00
Heron Therapeutics (HRTX) United States $0.213B 0.00
OmniAb (OABI) United States $0.201B 0.00
Aclaris Therapeutics (ACRS) United States $0.199B 0.00
MediWound (MDWD) Israel $0.182B 0.00
Journey Medical (DERM) United States $0.177B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
MEI Pharma (MEIP) United States $0.171B 0.00
China SXT Pharmaceuticals (SXTC) China $0.169B 0.00
Achieve Life Sciences (ACHV) Canada $0.161B 0.00
Inhibikase Therapeutics (IKT) United States $0.137B 0.00
Profound Medical (PROF) Canada $0.136B 0.00
Avalo Therapeutics (AVTX) United States $0.123B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.121B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Avita Medical (RCEL) United States $0.117B 0.00
Cassava Sciences (SAVA) United States $0.115B 0.00
Wellgistics Health (WGRX) United States $0.113B 0.00
Surrozen (SRZN) United States $0.100B 0.00
Dominari Holdings (DOMH) United States $0.096B 0.00
Cardiol Therapeutics (CRDL) Canada $0.091B 0.00
Champions Oncology (CSBR) United States $0.091B 20.69
BioNxt Solutions (BNXTF) Canada $0.087B 0.00
Pyxis Oncology (PYXS) United States $0.082B 0.00
VAXART, INC (VXRT) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.079B 0.00
Assertio Holdings (ASRT) United States $0.078B 0.00
Context Therapeutics (CNTX) United States $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.076B 0.00
Unicycive Therapeutics (UNCY) United States $0.074B 0.00
Prelude Therapeutics (PRLD) United States $0.074B 0.00
Nutriband (NTRB) United States $0.073B 0.00
Liminatus Pharma (LIMN) United States $0.072B 0.00
Metagenomi (MGX) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Gain Therapeutics (GANX) United States $0.068B 0.00
Karyopharm Therapeutics (KPTI) United States $0.067B 0.00
DURECT (DRRX) United States $0.060B 0.00
Inotiv (NOTV) United States $0.058B 0.00
PolyPid (PYPD) Israel $0.054B 0.00
Rafael Holdings (RFL) United States $0.054B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 31.55
Jupiter Neurosciences (JUNS) United States $0.051B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Fractyl Health (GUTS) United States $0.050B 0.00
Plus Therapeutics (PSTV) United States $0.049B 0.00
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
FibroGen (FGEN) United States $0.045B 0.00
Klotho Neurosciences (KLTO) United States $0.044B 0.00
Tempest Therapeutics (TPST) United States $0.044B 0.00
Century Therapeutics (IPSC) United States $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
SCYNEXIS (SCYX) United States $0.036B 0.00
Vivos Therapeutics (VVOS) United States $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.031B 0.00
Iterum Therapeutics (ITRM) Ireland $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Relmada Therapeutics (RLMD) United States $0.026B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
Mangoceuticals (MGRX) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Scienture Holdings (SCNX) United States $0.021B 0.00
Ainos (AIMD) United States $0.019B 0.00
Incannex Healthcare (IXHL) Australia $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Aptorum Group (APM) United Kingdom $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
ESSA Pharma (EPIX) Canada $0.011B 0.00
TNF Pharmaceuticals (TNFA) United States $0.011B 0.00
Heatwurx (PCSA) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.010B 0.02
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Carisma Therapeutics (CARM) United States $0.010B 0.00
CERo Therapeutics Holdings (CERO) United States $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Vyome Holdings (HIND) United States $0.006B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Aditxt (ADTX) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
CDT Equity (CDT) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
SHINECO (SISI) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Indivior (INDV) United States $0.000B 13.42
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.61
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00